Method for reduction of cardiac mortality rate using pyrazolidin

Details Method for reduction of cardiac mortality rate using pyrazolidin Method for reduction of cardiac mortality rate using pyrazolidin

1979-05-07

1981-03-10

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Parasitic organism or component thereof or substance...

A61K 31415

Patent

active

042554381

ABSTRACT:
Pharmaceutical compositions comprising a substituted pyrazolidine-3,5-dione, e.g. the 1,2-diphenyl-4-(2-phenylthioethyl or 2-phenylsulfinylethyl)-pyrazolidine-3,5-dione, or a salt thereof with a base, are useful in the treatment of cardiovascular diseases.

REFERENCES:
patent: 2700671 (1955-01-01), Hafliger
patent: 3752894 (1973-08-01), Esteve
patent: 3760080 (1973-09-01), Urwyler
patent: 3833729 (1974-09-01), Negrevergne
Platelets, Drugs & Thombosis Sym.--Blakely et al., pp. 284-291 (1972).
New Eng. J. Med. 298, pp. 289-295 (1978).

Affiliated with

Also associated with

Rating

Method for reduction of cardiac mortality rate using pyrazolidin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for reduction of cardiac mortality rate using pyrazolidin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reduction of cardiac mortality rate using pyrazolidin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1294200